Typhoid and Paratyphoid Fever

Tropical Diseases in Travelers

Volumn , Issue , 2010, Pages 144-153

  Schwartz, Eli ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Enteric fever; Paratyphoid fever; S. paratyphi; S. typhi; Typhoid fever

Indexed keywords

EID: 84886058349     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444316841.ch16     Document Type: Chapter

References (50)

1. DeRoeck D, Jodar L, Clemens J. Putting typhoid vaccination on the global health agenda.N Engl J Med 2007;357:1069-71.
2. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002;347:1770-82.
3. Ivanoff B. Typhoid fever: global situation and WHO recommendations. Southeast Asian J Trop Med Public Health 1995;26(suppl 2):1-6.
4. Crump JA, Luby SP,Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004;82:346-53.
5. Lin FY, Ho VA Bay PV, et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg 2000;62:644-8.
6. Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children less than 5 years. Lancet 1999;354:734-7.
7. Taylor DN, Pollard RA, Blake PA. Typhoid in the United States and the risk to the international traveler. J Infect Dis 1983;148:599-602.
8. Ryan CA, Hargrett-Bean NT, Blake PA. Salmonella typhi infections in the United States, 1975-1984: increasing role of foreign travel. Rev Infect Dis 1988;2:1-8.
9. Mermin JH,Townes JM, GerberM, et al.Typhoid fever in the United States, 1985-1994. Arch Intern Med 1998;158:633-8.
10. Meltzer E. Yosipovitch O., Sadik C., Dan M, Schwartz E. Epidemiology and clinical aspects of typhoid fever in Israel. Am J Trop Med Hyg 2006;74:540-45
11. Lester A, Mygind O, Jensen KT, Jarlov JO, Schonheyder HC. Typhoid and paratyphoid fever in Denmark 1986-1990. Epidemiologic aspects and the extent of bacteriological followup of patients. Ugeskr Laeger 1994;156:3770-5.
12. Yew FS, Goh KT, Lim YS. Epidemiology of typhoid fever in Singapore. Epidemiol Infect 1993 Feb; 110: 63-70.
13. Lighton LL. Follow up in north west England of cases of enteric fever acquired abroad, April 1996 to March 1998. Commun Dis Public Health 1999;2:145-6.
14. UK Department of Health. Typhoid. In: Salisbury DM, Begg NT, editors. Immunisation against Infectious Disease. London: UK Department of Health; 1996. p. 243-9.
15. Behrens R, Carroll B. The 10 year trend of travel associated infections imported into the U.K. In: Proceedings of the 7th Conference of the International Society of Travel Medicine (CISTM7), Innsbruck 2001; p. 86.
16. Meltzer E, Sadik C, Schwartz E. Enteric fever in Israeli travelers: a nation-wide study. J. Travel Med. 2005;12:275-81.
17. Caumes E, Ehya N, Nguyen J, et. al. Typhoid and paratyphoid fever: a 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med 2001;8:293-7.
18. Jelinek T, Nothfurft HD, Sonnenburg FV, et al. Risk factors for typhoid fever in travelers. J Travel Med 1996;3:200-203.
19. O'Brien D, Tobin S, Brown GV, et al. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis 2001;33:603-9.
20. Steinberg EB, Bishop R,Haber P, Dempsey AF,Hoekstra RM, Nelson JM, Ackers M, Calugar A,Mintz ED. Typhoid fever in travelers: who should be targeted for prevention? Clin Infect Dis 2004;39:186-91.
21. Leder K, Tong S, Weld L, et al.GeoSentinel Surveillance Network. Illness in travelers visiting friends and relatives: a review of the GeoSentinel surveillance network. Clin Infect Dis 2006 1;43:1185-93.
22. Safdar A,Kaur H, Elting L,Rolston KV.Antimicrobial susceptibility of 128 Salmonella enterica serovar typhi and paratyphi A isolates from northern India. Chemotherapy 2004;50: 88-91.
23. Schwartz E, Shlim DR, Eaton M, et al. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch Intern Med 1990;150:349-51.
24. Ochiai RL,Wang X, von Seidlein L, et al. Salmonella paratyphi A rates, Asia. Emerg Infect Dis 2005;11:1764-6.
25. Shlim DR, Schwartz E, Eaton M. Clinical importance of Salmonella paratyphi A infection to enteric fever in Nepal. J Travel Med 1995;2:165-8.
26. Edelman R, Levine MM. Summary of an international workshop on typhoid fever. Rev Infect Dis 1986;8:329-49.
27. Khosla SN. Typhoid hepatitis. Postgrad Med J 1990;66:923-5.
28. Schwartz E, Jenks NP, Shlim DR. 'Typhoid hepatitis' or typhoid fever and acute viral hepatitis. Trans R Soc Trop Med Hyg 1994;88:437-8.
29. Olopoenia LA, King AL.Widal agglutination test-100 years later: still plagued by controversy. Postgrad Med J 2000;76: 80-84.
30. World Health Organization. The Diagnosis, Treatment and Prevention of Typhoid Fever.World Health Organization;May 2003.
31. Sanchez-Jimenez MM, Cardona-Castro N. Validation of a PCR for diagnosis of typhoid fever and salmonellosis by amplification of the hilA gene in clinical samples from Colombian patients. J Med Microbiol 2004;53:875-8.
32. Wain J, Diep TS, Ho VA, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998;36:1683-7.
33. Gilman RH, Terminel M, Levine MM, et al. Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet 1975;1(7918):1211-13.
34. Gupta A. Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach. Pediatr Infect Dis J 1994;13:134-40.
35. Mermin JH, Villar R, Carpenter J, et al. A massive epidemic of multi-drug resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 1999;17:1416-22.
36. Alam MN, Haq SA, Das KK, et al. Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella. Am J Trop Med Hyg 1995;53: 306-11.
37. Murdoch DA, Banatvala NA, Bone A, et. al. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 1998;351:339.
38. Parry C, Wain J, Chinh NT, e al. Quinolone resistant Salmonella typhi in Vietnam. Lancet 1998;351:3.
39. Parry CM.The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 2004;98:413-22.
40. Frenck RW, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000;31:1134-8.
41. Slinger R,Desjardins M,McCarthy AE, et al. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis. 2004;20(4)(1):36.
42. Piersma D,Overbosch D, Petit P, van Genderen PJ. Protracted fever after a journey to India and Nepal: a case of persistent Salmonella paratyphi infection. J Travel Med 2004;11:257-9.
43. Girgis NI, Butler T, Frenck RW, Sultan Y, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999;43:1441-4.
44. Chinh NT, Parry CM, Ly NT, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 2000;44:1855-9.
45. Engels EA, Falagas ME, Lau J, et al. Typhoid fever vaccines: ameta-analysis of studies on efficacy and toxicity. BMJ 1998;316:110-16.
46. Stubi CL, Landry PR, Petignat C, et al. Compliance to live oral Ty21a typhoid vaccine and its effect on viability. J Travel Med 2000;7:133-7.
47. Cryz SJ. Patient compliance in the use of Vivotif Berna® vaccine, typhoid vaccine, live oral Ty21a. J Travel Med 1998;5: 14-17.
48. Lanh, MN, Lin FYC, Bay PV, et al. Persistence of antibodies and efficacy against typhoid fever 28-46 months following Vi conjugate vaccine (Vi-rEPA) in 2 to 5 years-old children. N Engl J Med 2003 349:1390-91.
49. Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Clin Infect Dis 2007;45 Suppl 1:S24-S28.
50. Connor BA, Schwartz E. Typhoid and paratyphoid fever in travelers. Lancet Infect Dis 2005;5:623-8.